HIMS & HERS HEALTH INC (HIMS:NYSE)
$27.59 -0.12 (-0.4331%)
Analysed HIMS & HERS HEALTH INC (HIMS:NYSE) News Sources
What Are Hims & Hers Health Stock Bears Missing?
19-10-2026
trefis.com
HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy
20-10-2026
stocktwits.com
Hims & Hers Gains as It Launches Men’s Weight-Loss Care in Germany
20-10-2026
tikr.com
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
21-10-2026
yahoo.com
Telehealth Firm Hims & Hers Seeks Dismissal Of FTC Privacy And Subscription Lawsuit
22-10-2026
stocktwits.com
Hims & Hers Stock Has Barely Moved Since Its Biggest Men’s Health Launch. Here’s What November 9 Has to Show
23-10-2026
tikr.com
Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint
23-10-2026
yahoo.com
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
23-10-2026
yahoo.com
Hims & Hers Health (HIMS) Debuts Injectable And Oral Testosterone Therapies
24-10-2026
yahoo.com
What Bears Saw Before Hims & Hers Health Slid
25-10-2026
yahoo.com
What is the current price of HIMS & HERS HEALTH INC (HIMS:NYSE)?
The current price of HIMS & HERS HEALTH INC (HIMS:NYSE) is $27.59.
HIMS & HERS HEALTH INC (HIMS:NYSE) absolute price change since previous trading day?
The absolute price change of HIMS & HERS HEALTH INC (HIMS:NYSE) since the previous trading day is $-0.12.
HIMS & HERS HEALTH INC (HIMS:NYSE) percentage price change since previous trading day?
The percentage price change of HIMS & HERS HEALTH INC (HIMS:NYSE) since the previous trading day is -0.4331%.
What is the most recent average sentiment score for HIMS & HERS HEALTH INC (HIMS:NYSE)?
The most recent average sentiment score for HIMS & HERS HEALTH INC (HIMS:NYSE) is 54 out of 100.
What is the most recent average sentiment for HIMS & HERS HEALTH INC (HIMS:NYSE)?
The most recent sentiment for HIMS & HERS HEALTH INC (HIMS:NYSE) is .
SEC-8K** Filing Available For HIMS & HERS HEALTH INC (HIMS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.